Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Novel mitral valve device shows encouraging mortality data

Key clinical point: Three- and 5-year survival outcomes are favorable with Carillon Mitral Contour System for mitral valve repair.

Major finding: The 67.9% survival at 36 months with the Carillon device is lower than that reported for the MitraClip.

Data Source: Pooled analysis of prospective studies.

Disclosures: Dr. Lipiecki reports no financial relationships relevant to this study.

Citation:

CRT 2020.